Literature DB >> 1542056

Metabolic heterogeneity of hepatocytes across the liver acinus.

N R Katz1.   

Abstract

Periportal hepatocytes around the afferent vessels and perivenous hepatocytes around the efferent vessels of the liver acinus exhibit different metabolic capacities and subcellular structures. This observation led to the concept of the metabolic zonation of the liver acinus. Oxidative energy metabolism, gluconeogenesis, urea synthesis, bile formation and protective metabolism are catalyzed mainly in the periportal zone; glycolysis linked to liponeogenesis, glutamine synthesis and xenobiotic metabolism are predominant in the perivenous zone. This zonation is dynamic rather than static. Zonation develops gradually, depending on perinatal changes of the hepatic circulation and on postnatal alterations of the supply with energy substrates. Zonation also is modulated during puberty. Moreover, adaptation to longer-lasting physiological and pathological alterations occurs as observed during starvation and refeeding, diabetes and regeneration after partial hepatectomy or zonal necrosis. Periportal to perivenous gradients of oxygen, hormones and metabolites, as well as zonal differences in the hepatic innervation, seem to be responsible for the heterogeneous gene expression within the liver acinus.

Entities:  

Mesh:

Year:  1992        PMID: 1542056     DOI: 10.1093/jn/122.suppl_3.843

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  30 in total

Review 1.  Physiology of bile secretion.

Authors:  Alejandro Esteller
Journal:  World J Gastroenterol       Date:  2008-10-07       Impact factor: 5.742

2.  OCT1 in hepatic steatosis and thiamine disposition.

Authors:  Ligong Chen; Sook Wah Yee; Kathleen M Giacomini
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

3.  A model to explain specific cellular communications and cellular harmony:- a hypothesis of coupled cells and interactive coupling molecules.

Authors:  Cyril J Craven
Journal:  Theor Biol Med Model       Date:  2014-09-14       Impact factor: 2.432

4.  Gradient Hydrogels.

Authors:  Antonina Lavrentieva
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

5.  Zonation of hepatic fat accumulation: insights from mathematical modelling of nutrient gradients and fatty acid uptake.

Authors:  Jana Schleicher; Uta Dahmen; Reinhard Guthke; Stefan Schuster
Journal:  J R Soc Interface       Date:  2017-08       Impact factor: 4.118

6.  Naphthylnitrobutadienes as pharmacologically active molecules: evaluation of the in vivo antitumour activity.

Authors:  Giovanni Petrillo; Carla Fenoglio; Emanuela Ognio; Cinzia Aiello; Domenico Spinelli; Maria A Mariggiò; Massimo Maccagno; Stefano Morganti; Cinzia Cordazzo; Maurizio Viale
Journal:  Invest New Drugs       Date:  2007-06-16       Impact factor: 3.850

7.  Individual mouse alpha-fetoprotein enhancer elements exhibit different patterns of tissue-specific and hepatic position-dependent activities.

Authors:  T M Ramesh; A W Ellis; B T Spear
Journal:  Mol Cell Biol       Date:  1995-09       Impact factor: 4.272

8.  Simulating microdosimetry in a virtual hepatic lobule.

Authors:  John Wambaugh; Imran Shah
Journal:  PLoS Comput Biol       Date:  2010-04-22       Impact factor: 4.475

9.  OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin.

Authors:  Ligong Chen; Yan Shu; Xiaomin Liang; Eugene C Chen; Sook Wah Yee; Arik A Zur; Shuanglian Li; Lu Xu; Kayvan R Keshari; Michael J Lin; Huan-Chieh Chien; Youcai Zhang; Kari M Morrissey; Jason Liu; Jonathan Ostrem; Noah S Younger; John Kurhanewicz; Kevan M Shokat; Kaveh Ashrafi; Kathleen M Giacomini
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-24       Impact factor: 11.205

10.  Absolute Quantification of Rifampicin by MALDI Imaging Mass Spectrometry Using Multiple TOF/TOF Events in a Single Laser Shot.

Authors:  Boone M Prentice; Chad W Chumbley; Richard M Caprioli
Journal:  J Am Soc Mass Spectrom       Date:  2016-09-21       Impact factor: 3.109

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.